Viewing Study NCT00912327

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:11 AM
Ignite Modification Date: 2026-04-24 @ 9:57 AM
Study NCT ID: NCT00912327
Status: COMPLETED
Last Update Posted: 2012-02-15
First Post: 2009-06-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy and Safety Study of Imprime PGG With Cetuximab in Subjects With Stage IV KRAS-Mutated Colorectal Cancer
Sponsor: HiberCell, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Colorectal View
None KRAS mutation View
None Stage IV View
None Imprime PGG View
None Cetuximab View
None Immunotherapy View